FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to pharmaceutical and cosmetic industry, and represents a nanocomposition representing a disperse system of polyethylene glycol of molecular weight 1500 to 35000, most preferentially of molecular weight 6000, with coenzyme Q10, wherein the mass ratio of polyethylene glycol and coenzyme Q10 is within 1:1 to 15:1, preferentially 4:1 to 12:1, more preferentially approximately 10:1.
EFFECT: invention provides higher bioavailability and therapeutic efficacy.
4 cl, 11 ex, 2 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| SOLID NANOCOMPOSITION FOR DELIVERY OF BIOLOGICALLY ACTIVE SUBSTANCES | 2007 |
|
RU2351352C2 |
| METHOD FOR PRODUCTION OF SUGARS-BASED NANOCOMPOSITION | 2009 |
|
RU2410109C1 |
| PROCESS FOR PRODUCTION OF REDUCED FORM OF COENZYME Q | 2016 |
|
RU2613103C1 |
| LIPOSOMAL AGENT BASED ON UBIQUINOL AND PREPARATION METHOD THEREOF | 2015 |
|
RU2605616C1 |
| RAPID CATALYTIC METHOD FOR PREPARING RECOVERED FORM OF COENZYME Q10 TO BE USED IN PHARMACEUTICAL AND FOOD COMPOSITIONS | 2013 |
|
RU2535928C1 |
| WATER-SOLUBLE MOLECULAR INCLUSION COMPLEX OF REDUCED FORM OF COENZYME Q IN β-CYCLODEXTRIN AND METHOD FOR PREPARATION THEREOF | 2011 |
|
RU2509760C2 |
| UBIQUINOL COMPOSITION FOR PARENTERAL ADMINISTRATION AND METHOD FOR ITS PRODUCTION | 2016 |
|
RU2635993C1 |
| COMPOSITION WITH 6-DECAPRNYL-2,3-DIMETHOXY-5-METHYL-1,4-BENZOQUINONE FOR PARENTERAL INTRODUCTION AND METHOD OF ITS OBTAINING | 2009 |
|
RU2433820C2 |
| SOLID DISPERSIONS Q | 2016 |
|
RU2742579C2 |
| SOLID DISPERSION OF CINNARIZINE | 2021 |
|
RU2776962C1 |
